Provided by Tiger Trade Technology Pte. Ltd.

Toyota

242.62
+0.89000.37%
Post-market: 242.00-0.6200-0.26%19:50 EST
Volume:201.23K
Turnover:48.87M
Market Cap:316.13B
PE:13.42
High:244.00
Open:243.17
Low:241.79
Close:241.73
52wk High:248.90
52wk Low:155.00
Shares:1.30B
Float Shares:975.98M
Volume Ratio:0.76
T/O Rate:0.02%
Dividend:6.10
Dividend Rate:2.51%
EPS(TTM):18.07
EPS(LYR):24.01
ROE:10.03%
ROA:2.73%
PB:1.26
PE(LYR):10.10

Loading ...

Press Release: Nauticus Robotics, Inc. Announces Major Leadership Enhancements, Aquanaut Manufacturing Expansion, and Accelerated Growth Strategy

Dow Jones
·
Feb 19

Press Release: ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026

Dow Jones
·
Feb 19

Press Release: Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

Dow Jones
·
Feb 19

Press Release: BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

Dow Jones
·
Feb 19

Data Center Boom Hits Housing, Nuclear-Fuel Supplies

Dow Jones
·
Feb 19

Press Release: Upbound Group, Inc. Reports Fourth Quarter and Full Year 2025 Results

Dow Jones
·
Feb 19

Press Release: N-able Announces Fourth Quarter and Full-Year 2025 Results

Dow Jones
·
Feb 19

Press Release: Expro Group Holdings N.V. Announces Fourth Quarter 2025 Results and Full-Year 2026 Guidance

Dow Jones
·
Feb 19

Toyota Motor Recalls LandCruiser 300 Vehicles in Australia

MT Newswires Live
·
Feb 19

Toyota recalls some 2025-2026 Lexus LX 600 vehicles

TIPRANKS
·
Feb 19

Press Release: EncorVita(TM) Health Acquires Menopause and Sexual Health Education Platform to Expand Provider Training in Medical Aesthetic Clinics

Dow Jones
·
Feb 19

Press Release: RBC creates new AI Group to help bring top AI opportunities to market

Dow Jones
·
Feb 18

Press Release: QT Imaging Reports Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Feb 18

Press Release: Verastem Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Dow Jones
·
Feb 18

More Memory-Chip Manufacturing; U.S. Oil Gushes as Prices Plunge

Dow Jones
·
Feb 18

Press Release: Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

Dow Jones
·
Feb 18

Press Release: Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance

Dow Jones
·
Feb 18

Press Release: Ingram Micro to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 2nd, 2026

Dow Jones
·
Feb 18

Press Release: BioArctic Interim Report for the period October - December 2025

Dow Jones
·
Feb 18

Press Release: HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

Dow Jones
·
Feb 18